Necessity of Fine-Needle Aspiration in Probably Benign Sonographic Appearance of Thyroid Nodules

Document Type : Original

Authors

1 Department of Radiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Department of Internal, Faculty of Medicine Mashhad University of Medical Sciences, Mashhad, Iran.

4 Department of Pathology, Faculty of Medicine Mashhad University of Medical Sciences, Mashhad, Iran.

5 Clinical Research Units, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Introduction:
The management of thyroid nodules has been proposed based on US features and information obtained from Fine-Needle Aspiration Cytology (FNAC). In this study, we checked the diagnostic value of ultrasound in comparison with FNAC in probably benign nodules of thyroid.
Materials and Methods:
Patients with thyroid nodules referred to the Radiology department from 2015 to 2020, were classified into five types based on the American College of Radiology/thyroid imaging reporting and data system (TI-RADS) standards. The patients with TI-RADS III-V were examined by FNA biopsy. Subsequently, the collected data of 535 patients having thyroid nodules with TI-RADS III were statistically analyzed.
Results:
The mean age of the patients was estimated at 46.57. The analysis of TI-RADS III cases examined by the FNA biopsy revealed that 99.1% of the cases were diagnosed with benign lesions. The mean size of benign and malignant nodules was 27mm and 41mm, respectively. There was no significant correlation between the size of the nodules or patients age, and thyroid malignancy (P-values > 0.05).
Conclusion:
There was a very low chance of malignancy (0.9%) in thyroid nodules with thyroid imaging classification of TI-RADS III. Furthermore, no meaningful correlation was observed between the size of the nodules and their malignancy. Therefore, the use of FNAC, based on the current guidelines, on thyroids for nodules larger than 2.5 cm might need to be revised.

Keywords


  1. Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules: final report of a 15-year study of the incidence of thyroid malignancy. Annals of internal medicine. 1968; 69(3):537-40.
  2. Tunbridge W, Evered D, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clinical endocrinology. 1977;7(6):481-93.
  3. Cappelli C, Castellano M, Pirola I, Gandossi E, De Martino E, Cumetti D, et al. Thyroid nodule shape suggests malignancy. European journal of endocrinology. 2006;155(1):27-31.
  4. Cooper D. American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-214.
  5. Sánchez JF. TI-RADS classification of thyroid nodules based on a score modified according to ultrasound criteria for malignancy. Rev Argent Radiol. 2014;78(3):138-48.
  6. Raggiunti B, Capone F, Franchi A, Fiore G, Filipponi S, Colagrande V, et al. Ultrasoundelastography: Can it provide valid information for differentiation of benign and malignant thyroid nodules? Journal of ultrasound. 2011; 14(3):136-41.
  7. Moon W-J, Jung SL, Lee JH, Na DG, Baek J-H, Lee YH, et al. Benign and malignant thyroid nodules: US differentiation-multicenter retrospective study. Radiology. 2008; 247(3): 762-70.
  8. Kwak JY, Han KH, Yoon JH, Moon HJ, Son EJ, Park SH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011;260(3):892-9.
  9. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. The Journal of Clinical Endocrinology & Metabolism. 2002; 87(5):1941-6.
  10. Tessler FN, Middleton WD, Grant EG, Hoang JK, Berland LL, Teefey SA, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. Journal of the American college of radiology. 2017; 14(5):587-95.
  11. Moon W-J, Baek JH, Jung SL, Kim DW, Kim EK, Kim JY, et al. Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean journal of radiology. 2011;12(1):1-14.
  12. Kwak JY. Indications for fine needle aspiration in thyroid nodules. Endocrinology and Metabolism. 2013; 28(2):81-5.
  13. Shin JJ, Caragacianu D, Randolph GW. Impact of thyroid nodule size on prevalence and post-test probability of malignancy: a systematic review. The Laryngoscope. 2015;125(1):263-72.
  14. Kamran SC, Marqusee E, Kim MI, Frates MC, Ritner J, Peters H, et al. Thyroid nodule size and prediction of cancer. The Journal of Clinical Endocrinology & Metabolism. 2013;98(2):564-70.
  15. Hammad AY, Noureldine SI, Hu T, Ibrahim Y, Masoodi HM, Kandil E. A meta-analysis examining the independent association between thyroid nodule size and malignancy. Gland surgery. 2016;5(3):312.
  16. McHenry CR, Huh ES, Machekano RN. Is nodule size an independent predictor of thyroid malignancy? Surgery. 2008;144(6):1062-8; discussion 8-9.
  17. Shrestha M, Crothers BA, Burch HB. The impact of thyroid nodule size on the risk of malignancy and accuracy of fine-needle aspiration: a 10-year study from a single institution. Thyroid. 2012; 22(12):1251-6.
  18. Cavallo A, Johnson DN, White MG, Siddiqui S, Antic T, Mathew M, et al. Thyroid nodule size at ultrasound as a predictor of malignancy and final pathologic size. Thyroid. 2017;27(5):641-50.
  19. Hong MJ, Na DG, Baek JH, Sung JY, Kim J-H. Impact of Nodule Size on Malignancy Risk Differs according to the Ultrasonography Pattern of Thyroid Nodules. Korean journal of radiology. 2018; 19(3):534-41.
  20. Rahemi KS, Alamdaran SA, Bonakdaran S, Morovatdar N, Jafarain AH, Hadadzade A, et al. New proposed formula of TI-RADS classification based on ultrasound findings. Acta Endocrinol (Buchar). 2020; 16(2): 199–207.